Troleandomycin
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Multum Consumer Information |
| MedlinePlus | a604026 |
| ATC code | J01FA08 (WHO) |
| Identifiers | |
| |
| CAS Number |
2751-09-9 |
| PubChem (CID) | 5284630 |
| DrugBank |
DB01361 |
| ChemSpider |
4447675 |
| UNII |
C4DZ64560D |
| KEGG |
D01322 |
| ChEBI |
CHEBI:45735 |
| ChEMBL |
CHEMBL564085 |
| ECHA InfoCard | 100.018.539 |
| Chemical and physical data | |
| Formula | C41H67NO15 |
| Molar mass | 813.968 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Troleandomycin is a macrolide antibiotic. It is sold in Italy (branded Triocetin) and Turkey (branded Tekmisin).
Troleandomycin is a CYP3A4 inhibitor that may cause drug interactions.
This article is issued from Wikipedia - version of the 9/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
